Extracellular domain shedding influences specific tumor uptake and organ distribution of the EGFR PET tracer 89Zr-imgatuzumab-Reference-Cited by-同舟云学术

Extracellular domain shedding influences specific tumor uptake and organ distribution of the EGFR PET tracer 89Zr-imgatuzumab

Published:2016-09-02 Issue:42 Volume:7 Page:68111-68121
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Pool Martin¹,Kol Arjan¹,Lub-de Hooge Marjolijn N.²³,Gerdes Christian A.⁴,de Jong Steven¹,de Vries Elisabeth G.E.¹,Terwisscha van Scheltinga Anton G.T.²

Affiliation:

1. Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands

2. Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands

3. Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands

4. Department of Roche Pharma Research and Early Development, Roche Innovation Center Zürich, Schlieren, Switzerland

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ImmunoPET: Antibody-Based PET Imaging in Solid Tumors;Frontiers in Medicine;2022-06-28

2. Radiopharmaceuticals developed for 89Zr-Immuno-PET;Journal of Radioanalytical and Nuclear Chemistry;2021-08-18

3. Correlations between serum cetuximab and EGFR-related markers, and skin disorders in head and neck cancer patients;Cancer Chemotherapy and Pharmacology;2021-01-19

4. Strategies to enhance monoclonal antibody uptake and distribution in solid tumors;Cancer Biology and Medicine;2021

5. PET/CT and the Response to Immunotherapy in Lung Cancer;Current Radiopharmaceuticals;2020-11-30